Stimulants and HIV: Addressing Contemporary and Recurring Epidemics (R61/R33 - Clinical Trial Required)

From US Department of Health & Human Services: National Institutes of Health (NIH)

The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

Type of Support

Overview

The grant focuses on addressing the complex issues arising from stimulant use among opioid users and its contribution to the opioid epidemic and HIV cases, particularly among gay men and other MSM. It highlights the need for new initiatives to incorporate emerging treatments for stimulant use, especially in the context of polysubstance use that includes opioids. The grant seeks applications that explore motivations and contexts for stimulant use to implement more effective interventions. Applications are accepted from October 22, 2022, through November 12, 2024.

Eligibility

Organization's Location
reprehenderit nisi
Program Location
pariatur
Organization Type
up to 400k

Submission

Visit Apply for more information.

Similar grants